Tag: offices

As global football's ultimate spectacle kicks off on June 12, the 'Aleph Arena' digital hub will host one match per day and over 5,000...

LONDON, June 10, 2026 /PRNewswire/ -- ICIS, a global leader in commodity intelligence, has secured exclusive access to the AMI Polymer Demand and Plastics Processors database,...

LONDON, June 10, 2026 /PRNewswire/ -- ICIS, a global leader in commodity intelligence, has secured exclusive access to the AMI Polymer Demand and Plastics Processors database,...

SHANGHAI, June 10, 2026 /PRNewswire/ -- Trinasolar, a global leader in smart PV and energy storage solutions, has signed a Memorandum of Understanding (MoU)...

AUSTIN, Texas and DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3 blocking antibodies for the treatment of patients with inflammatory and immune-mediated diseases, today announced the pricing of its previously announced a public offering of 10,879,376 shares of its common stock at a public offering price per share of $4.00 and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to 7,870,624 shares of its common stock at a public offering price of $3.9999 per pre-funded warrant. The pre-funded warrants have an exercise price of $0.0001 per share and are exercisable immediately. The aggregate gross proceeds to Shattuck from the offering are expected to be approximately $75 million before deducting underwriting discounts and commissions and other offering expenses payable by Shattuck, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on June 11, 2026, subject to the satisfaction of customary closing conditions. In addition, Shattuck has granted the underwriters an option for a period of 30 days to purchase up to an additional 2,812,500 shares of its common stock at the public offering price, less underwriting discounts and commissions.

GeneDx (WGS) Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit

Minami Maeda appointed as CEO to drive faster, more focused execution toward U.S. commercial launchMickey Mikitani will continue to provide strategic direction and remains...

SINGAPORE, June 10, 2026 /PRNewswire/ -- SUNRATE, the global payment and treasury management platform, today unveiled Sunrate.AI at SuperAI, defining 'Agentic Global Payments' —...

LEXINGTON, Ky., June 9, 2026 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ: METC, METCB) ("Ramaco" or the "Company") today announced that Jeremy Sussman, Chief Financial...

HyOrc Corporation Retains Stonegate Capital Partners to Lead Investor Outreach and Support Nasdaq Uplisting Strategy

The Only Exclusively MedTech Firm Among the Top 175 of 22,000+ US Recruiting Firms.ORLANDO, Fla., June 9, 2026 /PRNewswire/ -- For the tenth time...

Postal Service and Ralph Lauren dedicate American Icons in unveiling ceremonyNEW YORK, June 9, 2026 /PRNewswire/ -- The U.S. Postal Service today honored the...